Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 5.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.52 | 1.42 |
NAV | ₹89.14 | ₹108.49 |
Fund Started | 12 Jun 2007 | 08 Apr 2008 |
Fund Size | ₹41750.19 Cr | ₹69762.55 Cr |
Exit Load | Exit load of 1% if redeemed within 7 days. | Exit load of 1% if redeemed upto 1 year. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 5.85% | 6.77% |
3 Year | 24.42% | 21.54% |
5 Year | 26.61% | 23.96% |
1 Year
3 Year
5 Year
Equity | 98.05% | 92.69% |
Cash | 1.95% | 6.45% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 8.64% |
Reliance Industries Ltd. | 7.16% |
ICICI Bank Ltd. | 5.89% |
Axis Bank Ltd. | 4.71% |
Larsen & Toubro Ltd. | 3.87% |
State Bank of India | 3.44% |
Bajaj Finance Ltd. | 3.42% |
ITC Ltd. | 3.08% |
GE Vernova T&D India Ltd. | 2.81% |
Infosys Ltd. | 2.55% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.66% |
ICICI Bank Ltd. | 8.99% |
Reliance Industries Ltd. | 6.40% |
Larsen & Toubro Ltd. | 6.26% |
Bharti Airtel Ltd. | 4.45% |
Axis Bank Ltd. | 4.31% |
Maruti Suzuki India Ltd. | 4.16% |
Ultratech Cement Ltd. | 3.81% |
Infosys Ltd. | 3.46% |
Sun Pharmaceutical Industries Ltd. | 2.72% |
Name | Akshay Sharma | Vaibhav Dusad |
Start Date | 01 Dec 2022 | 02 May 2020 |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation by investing predominantly into equity and equity related instruments of large cap companies. | The scheme seeks to generate long term capital appreciation and income distribution to investors from a portfolio that is predominantly invested in equity and equity related securities of large cap companies. |
Launch Date | 12 Jun 2007 | 08 Apr 2008 |
Description
Launch Date